Fusion Protein Technologies for Biopharmaceuticals

The state of the art in biopharmaceutical FUSION PROTEIN DESIGN Fusion proteins belong to the most lucrative biotech drugs—with Enbrel being one of the best-selling biologics worldwide. Enbrel represents a milestone of modern therapies ju...